XB-ART-15968
J Pharmacol Exp Ther
1997 Sep 01;2823:1458-64.
Show Gene links
Show Anatomy links
Lead inhibition of N-methyl-D-aspartate receptors containing NR2A, NR2C and NR2D subunits.
???displayArticle.abstract???
The potency of Pb2+ inhibition of glutamate-activated currents mediated by N-methyl-D-aspartate (NMDA) receptors was dependent on the subunits composing the receptors when functionally expressed in Xenopus laevis oocytes. Pb2+ reduced the amplitudes of glutamate-activated currents and shifted the agonist EC50 values of NMDA receptors consisting of different subunit compositions. The IC50 values for Pb2+ ranged from 1.52 to 8.19 microM, with a rank order of potency of NR1b-2A > NR1b-2C > NR1b-2D > NR1b-2AC. For NR1b-2AC NMDA receptors, the IC50 value was dependent on the agonist concentration; at saturating agonist concentrations (300 microM), the IC50 value was 8.19 microM, whereas at 3 microM glutamate, the IC50 value was 3.39 microM. Pb2+ was a noncompetitive inhibitor of NR1b-2A, NR1b-2C and NR1b-2D NMDA receptors. At low concentrations (<1 microM) Pb2+ potentiated NR1b-2AC NMDA receptors. These data provide further evidence to support the hypothesis that the actions of Pb2+ on NMDA receptors are determined by the receptor subunit composition.
???displayArticle.pubmedLink??? 9316859
???displayArticle.link??? J Pharmacol Exp Ther
???displayArticle.grants???
Species referenced: Xenopus laevis
Genes referenced: grin2a grin2c grin2d